Abstract
Mammalian brain extracts contain a substance, "enkephalin," which competes for opiate receptor binding in a highly selective fashion. This material behaves in opiate receptor assays as an opiate agonist, with its effects enhanced by manganese and decreased by sodium. The regional distribution of enkephalin parallels that of the opiate receptor itself. Enkephalin activity is degraded by carboxypeptidases A and B and leucinaminopeptidase as well as by chymotrypsin, but is resistant to trypsin and neuraminidase. Thus enkephalin appears to be a peptide. Gel filtration experiments indicate a molecular weight of about 1000.
- Copyright © 1976 by Academic Press, Inc.
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.